Trends in Patch Test Results With the Mayo Clinic Extended Standard Series: A 14-Year Retrospective Review (2010–2023)
Dermatitis® · 01.03.2026 · 37 (2) · 230-237
DOI: 10.1089/derm.2025.0075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatitis®, online erschienen am 14.05.2025. Verfasst von Miguel A Aristizabal-Torres und 5 weiteren Autor:innen. Beteiligte Einrichtung: From the, Department of Dermatology, Mayo Clinic, Jacksonville, Florida, USA. Hauptthemen laut MEDLINE: Patch Tests, Dermatitis, Allergic Contact, Allergens. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Background
Extended patch testing beyond the standard series is commonly performed in patients with allergic contact dermatitis. This broader testing allows for more precise and complete allergen identification, ultimately leading to improved clinical outcomes.
Objective
To report the Mayo Clinic Contact Dermatitis Group (MCCDG) patch testing results using a custom extended series from 2010 to 2023.
Methods
A retrospective review of patch testing results using the MCCDG extended standard series at the Mayo Clinic was conducted. Data from 2010 to 2023 were analyzed.
Results
Patch testing with the extended standard series was performed in 3,767 unique patients, with a total of 3834 extended standard patch tests administered (81.8% in women, 18.2% in men). The top 5 allergens eliciting positive reactions were gold (I) sodium thiosulfate (10.4%), benzisothiazolinone (10.4%), carmine (9.4%), thimerosal (9.3%), and hydroperoxides of linalool (8.8%).
Conclusions
The extended standard series expands the diagnostic scope for patients in whom the standard series incompletely identifies relevant allergens. Preservatives and fragrances remain among the most common sensitizers, emphasizing the need for ongoing allergen surveillance, periodic review, and updates to patch test series to enhance diagnostic accuracy and patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the, Department of Dermatology, Mayo Clinic, Jacksonville, Florida, USA.
- Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Dermatology, Mayo Clinic, Scottsdale, Arizona, USA.
ORCID-Profile: Miguel A Aristizabal-Torres, Yul W Yang, Matthew R Hall
Zitieren
APA
Aristizabal-Torres, M. A., Youssef, M., Yang, Y. W., Yiannias, J. A., Davis, M. D. P., & Hall, M. R. (2026). Trends in Patch Test Results With the Mayo Clinic Extended Standard Series: A 14-Year Retrospective Review (2010–2023). Dermatitis®, 37(2), 230-237. https://doi.org/10.1089/derm.2025.0075
Vancouver
Aristizabal-Torres MA, Youssef M, Yang YW, Yiannias JA, Davis MDP, Hall MR. Trends in Patch Test Results With the Mayo Clinic Extended Standard Series: A 14-Year Retrospective Review (2010–2023). Dermatitis®. 2026;37(2):230-237. doi:10.1089/derm.2025.0075
BibTeX
@article{AristizabalTorres2026,
author = {Aristizabal-Torres, Miguel A and Youssef, Molly and Yang, Yul W and Yiannias, James A and Davis, Mark D P and Hall, Matthew R},
title = {Trends in Patch Test Results With the Mayo Clinic Extended Standard Series: A 14-Year Retrospective Review (2010–2023)},
journal = {Dermatitis®},
year = {2026},
volume = {37},
number = {2},
pages = {230--237},
doi = {10.1089/derm.2025.0075}
}
EUVIMED